APR 03, 2021 7:06 AM PDT

New factor plays a key role in immune response

In a study published recently in Science Immunology, WEHI’s Professor Stephen Nutt, Dr. Michael Chopin, and Mr. Shengbo Zhang have established the differentiation process that triggers the immune system to control cancer and infectious disease. The process identifies how a factor they’re calling DC-SCRIPT is necessary to trigger dendritic cells called cDC1 to produce an immune response.

The study explains how DC-SCRIPT is involved in producing the dendritic cells responsible for an immune reaction. Dendritic cells are immune cells that activate 'killer' T cells, the immune cells that attack viral infections elicit a response to tumors.

The researchers say that this knowledge will help the scientific and medical communities guide future investigations that aim to stimulate the human body to generate large numbers of dendritic cells, thus allowing for improved reactions to fight off cancer and infections.

"What we found, is that without this new factor, the cells develop poorly, and their capacity to fight infection and cancer, or to clear a parasite, is diminished," notes Professor Nutt. "The next stage of our research is to try and work out how we can get the body to produce these particular dendritic cells, cDC1s, in large volumes in order to boost the body's natural tumor response."

Dr. Chopin adds that cDC1s represent the potential to enhance immunity to viruses and tumors. "This paper clearly shows DC-SCRIPT is one of the regulators of dendritic cell production. As a result of this study, we're now focussed on ways we could harness this to increase dendritic cell production," he said. "We now have a biomarker to follow when we expand this elusive cell type, which we will continue to test in pre-clinical models. We have generated new tools, allowing us to trace these cells within the tumor and observe how they behave in the tumor environment.”

Sources: Science Immunology, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
FEB 04, 2021
Cancer
Microchip models tumor‐immune interactions to predict immunotherapy effectiveness
FEB 04, 2021
Microchip models tumor‐immune interactions to predict immunotherapy effectiveness
A team from the Terasaki Institute for Biomedical Innovation (TIBI) has developed a microchip system that models immune ...
FEB 23, 2021
Cancer
Quantifying cancer survivors' stress during the early months of the pandemic
FEB 23, 2021
Quantifying cancer survivors' stress during the early months of the pandemic
Approximately one-third of cancer survivors were psychologically distressed during the early months of the pandemic due ...
MAR 09, 2021
Cannabis Sciences
Cannabis Alleviates Neuropathic Pain from Chemotherapy
MAR 09, 2021
Cannabis Alleviates Neuropathic Pain from Chemotherapy
Neuropathic pain from oxaliplatin-based chemotherapy regimens occurs in up to 90% of patients, and continued exposure to ...
MAR 23, 2021
Clinical & Molecular DX
AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels
MAR 23, 2021
AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels
Researchers have developed a new way of differentiating cancer cells from healthy ones—by how acidic they are. The ...
MAR 23, 2021
Cancer
Examining the role that cholesterol plays in brain cancer
MAR 23, 2021
Examining the role that cholesterol plays in brain cancer
A study published recently in the journal Nature Communications reports on the role that cholesterol plays in the g ...
MAR 31, 2021
Cancer
Understanding the risk of thrombosis for cancer patients
MAR 31, 2021
Understanding the risk of thrombosis for cancer patients
New research from the Comprehensive Cancer Center (CCC) of Medical University of Vienna and Vienna General Hospital sugg ...
Loading Comments...